Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryEnterprise imaging AI platform for acute and longitudinal clinical workflows, including FDA-cleared imaging modules.
Hospitals evaluating stroke, vascular, aortic, hemorrhage, or other imaging workflows that need integrated alerts and care coordination.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating RapidAI as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Validate the selected RapidAI module against its own clearance, modality, anatomy, and intended use rather than applying platform claims across all workflows. |
|---|---|
| Privacy | Review edge, hybrid, on-prem, and cloud deployment choices; PACS/RIS/EHR integration; image routing; mobile notifications; DPF/privacy terms; data retention; uptime; audit logs; and cybersecurity requirements for acute-care use. |
| Evidence | Measure pathway-specific impact on notification timing, transfer decisions, false alerts, missed findings, and downstream outcomes during a controlled rollout. |
| Workflow | Best deployed where stroke, vascular, hemorrhage, or aortic teams have clear alert ownership, escalation rules, downtime procedures, and monitoring dashboards. |
RapidAI describes a clinical AI and enterprise imaging platform, including stroke, vascular, hemorrhage, and aortic workflows; its materials describe FDA-cleared modules, edge/cloud deployment choices, Data Privacy Framework terms, and healthcare security certifications.
Not for: Standalone diagnosis or deployment of any module outside its cleared intended use, modality, anatomy, or local workflow controls.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.